London's top regeneration zones: future new homes hotspots from Hounslow to Barking - London is finally building again.
Join ELRIG at the Advances in Cell-based Screening 2026 for key insights into drug discovery from top scientists.
NorthStrive Fund II LP ("NorthStrive Fund", "we", "our" or "us"), a subsidiary of NorthStrive Companies Inc., headquartered in Newport Beach, California, is a significant shareholder of Bluejay ...
Meningitis B latest: Urgent public health alert issued health chief warns cases may continue to rise - Canterbury Christ Church University confirms one case as vaccine rollout under way ...
BioVersys Announces First Patient Dosed in Phase 2b Clinical Trial of AlpE in Pulmonary Tuberculosis
Under the BioVersys and GSK collaboration agreement, AlpE clinical development advances with first patient dosed in Phase 2b trial within UNITE4TB, following completion of a Phase ...
Top articles include a new “GC Connections” article on maintenance practices for modern capillary gas chromatography (GC) systems, an interview on rapid per- and polyfluoralkyl substances (PFAS) ...
ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the ...
The story for February was the surging Australian dollar running into incredible profit growth forecasts. Profit forecasts got stronger throughout the month, helping share prices higher, but for ...
Leerink Global Healthcare Conference 2026 March 9, 2026 3:40 PM EDTCompany ParticipantsBrett Monia - Founder, CEO ...
Authorities face a race against time to vaccinate around 5,000 students in Kent University halls before the deadly strain of Meningitis B spreads further.
Detailed price information for Biodexa Pharmaceuticals Plc ADR (BDRX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results